Menu
Currency
GWAS Study

Overlap of Genetic Loci for Central Serous Chorioretinopathy With Age-Related Macular Degeneration.

Rämö JT, Abner E, van Dijk EHC et al.

37079300 PubMed ID
GWAS Study Type
344013 Participants
100 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

RJ
Rämö JT
AE
Abner E
VD
van Dijk EHC
WX
Wang X
BJ
Brinks J
NT
Nikopensius T
NM
Nõukas M
MH
Marjonen H
SK
Silander K
JS
Jukarainen S
KT
Kiiskinen T
CS
Choi SH
KR
Kajanne R
MJ
Mehtonen J
PP
Palta P
LS
Lubitz SA
KK
Kaarniranta K
SL
Sobrin L
KM
Kurki M
YS
Yzer S
EP
Ellinor PT
ET
Esko T
DM
Daly MJ
DH
den Hollander AI
PA
Palotie A
TJ
Turunen JA
BC
Boon CJF
RE
Rossin EJ
Chapter II

Abstract

Summary of the research findings

Importance: Central serous chorioretinopathy (CSC) is a serous maculopathy of unknown etiology. Two of 3 previously reported CSC genetic risk loci are also associated with AMD. Improved understanding of CSC genetics may broaden our understanding of this genetic overlap and unveil mechanisms in both diseases.

552 Finnish ancestry cases, 343,461 Finnish ancestry controls

Chapter III

Study Statistics

Key metrics and study information

344013
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Finland, Estonia
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.